Trial intelligence / Profile preview

MMF and Cyclosporine for Relapsing Aplastic Anemia

NCT00005935Phase 2Completed

Sponsor
National Heart, Lung, and Blood Institute
Start
Jun 2000
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of mycophenolate mofetil in aplastic anemia, sponsored by National Heart, Lung, and Blood Institute. Started Jun 2000; status: completed.

02

Drugs

mycophenolate mofetil
03

Conditions

aplastic anemia

Beyond the preview

Go deeper on NCT00005935.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00005935.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call